Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Terminas
30.06.2026
Paskelbta
26.10.2026
Sutartis suteikta
26.10.2026
Preliminary Market Engagement for Real Time Location System (
Priima pasiūlymus·Oct 19
Purchase of lightsouce
Sutartis suteikta·Oct 16
Purchase of Cardiotocography machines
Sutartis suteikta·Oct 12
Purchase of ENT Microscopes
Sutartis suteikta·Oct 7
Rental of 1 x Interventional Radiology Suite
Sutartis suteikta·Oct 6
Linen & Laundry - Managed Services
Sutartis suteikta·Sep 29
Histology Reporting
Sutartis suteikta·Oct 14
WSFT - Pathology - Bloodtrack software support
Sutartis suteikta·Oct 9
WSFT - Pathology - AlinIQ Indexor
Sutartis suteikta·Oct 9
WSFT - Pathology - Bloodtrack software support
Sutartis suteikta·Oct 1
WSFT - Managed Service - Pathology - Microbiology testing Pro-Lab Diagnostics
Sutartis suteikta·Sep 4
Pathology Managed Service for Midlands & East 2 Network
Sutartis suteikta·Jul 10
The Responsible Medical Officer (RMO) Braintree
Sutartis suteikta·Oct 26
The Purchase of 8 seater Vehicles
Sutartis suteikta·Oct 26
CPU 8676 Planting of meadow turf in three areas and 2 years of Establishment at St Peter's Street
Sutartis suteikta·Oct 26
26064 Cambridgeshire Carriageway Resurfacing 26/27 - Package 1 (Further Competition EHF 4, Lot 1)
Sutartis suteikta·Oct 26
37418 - West Gate School
Sutartis suteikta·Oct 26
Digital and Technology Solutions Apprenticeship Level 6
Sutartis suteikta·Oct 26
Susikurkite paskyrą, kad galėtumėte išnagrinėti šį pirkimą ir rasti panašių galimybių.